Bernard Doger
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 44
- Cancer Immunotherapy and Biomarkers 21
- Peptidase Inhibition and Analysis 7
- CAR-T cell therapy research 7
- Lung Cancer Research Studies 6
-
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Víctor Moreno (28 shared papers)Emiliano Calvo (19 shared papers)Martin Förster (14 shared papers)Frédéric Triebel (14 shared papers)Matthew Krebs (12 shared papers)Julio A. Peguero (12 shared papers)Maria J. de Miguel (6 shared papers)Enriqueta Felip (9 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)International Journal of Radiation Oncology*Biology*Physics (6 papers)Annals of Oncology (6 papers)European Journal of Cancer (3 papers)Cancer Research (3 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Bernard Doger
56 papers receiving 529 citations
Peers
Comparison fields: 5 of 69
- Oncology 349
- Immunology 125
- Pulmonary and Respiratory Medicine 123
- Otorhinolaryngology 16
- Hematology 28
Countries citing papers authored by Bernard Doger
This map shows the geographic impact of Bernard Doger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Doger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Doger more than expected).
Fields of papers citing papers by Bernard Doger
This network shows the impact of papers produced by Bernard Doger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Doger. The network helps show where Bernard Doger may publish in the future.
Co-authors
The 25 scholars most cited alongside Bernard Doger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 73 | |
| 2 | 2017 | 54 | |
| 3 | 2020 | 50 | |
| 4 | 2021 | 45 | |
| 5 | 2021 | 20 | |
| 6 | 2021 | 18 | |
| 7 | 2022 | 18 | |
| 8 | 2020 | 17 | |
| 9 | 2021 | 14 | |
| 10 | 2023 | 13 | |
| 11 | 2022 | 12 | |
| 12 | 2018 | 12 | |
| 13 | 2016 | 12 | |
| 14 | 2022 | 11 | |
| 15 | 2019 | 11 | |
| 16 | 2020 | 10 | |
| 17 | 2019 | 10 | |
| 18 | 2018 | 9 | |
| 19 | 2021 | 9 | |
| 20 | 2024 | 8 |
About Bernard Doger
Bernard Doger is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 61 papers that have together received 535 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), Lung Cancer Treatments and Mutations (8 papers), Peptidase Inhibition and Analysis (7 papers), CAR-T cell therapy research (7 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Immunotherapy and Immune Responses (6 papers), Lung Cancer Research Studies (6 papers) and Head and Neck Cancer Studies (6 papers). The work is most often cited by research in Oncology (349 citations), Immunology (125 citations), Pulmonary and Respiratory Medicine (123 citations), Otorhinolaryngology (16 citations) and Hematology (28 citations). Bernard Doger has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Víctor Moreno, Emiliano Calvo, Martin Förster, Frédéric Triebel, Matthew Krebs, Julio A. Peguero, Maria J. de Miguel, Enriqueta Felip, Irene Braña and Enric Carcereny. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology, European Journal of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.